IN2014MN00932A - - Google Patents
Info
- Publication number
- IN2014MN00932A IN2014MN00932A IN932MUN2014A IN2014MN00932A IN 2014MN00932 A IN2014MN00932 A IN 2014MN00932A IN 932MUN2014 A IN932MUN2014 A IN 932MUN2014A IN 2014MN00932 A IN2014MN00932 A IN 2014MN00932A
- Authority
- IN
- India
- Prior art keywords
- flavonoid
- meal
- glucoside
- management
- aglycone
- Prior art date
Links
- 229930003935 flavonoid Natural products 0.000 abstract 6
- 235000017173 flavonoids Nutrition 0.000 abstract 6
- 235000012054 meals Nutrition 0.000 abstract 5
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 abstract 3
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 abstract 3
- -1 flavonoid glucoside Chemical class 0.000 abstract 3
- 150000002215 flavonoids Chemical class 0.000 abstract 3
- 229930182478 glucoside Natural products 0.000 abstract 3
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 abstract 3
- 230000002265 prevention Effects 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 235000005118 dietary health Nutrition 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
- 230000037221 weight management Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Pediatric Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
This invention relates to a plurality of compositions for dietary health management and its use in the prevention or treatment of cardiovascular disease or type 2 diabetes and also in the prevention and/or management of obesity and generally in weight management and loss. Thus a meal intended for human consumption is provided the meal comprising: (a) 250 650 kilocalories (1045 4180 kiloJoules); (b) 10 50 preferably 20 50 more preferably 30 50 g fibre; (c) 10 50 preferably 10 30 more preferably 10 20 g protein; (d) 0 to 5 preferably less than 3 g starch; and (e) 0 to 2 preferably 0 to 1 most preferably 0 to 0.5 g lactose; (f) at least 20 preferably at least 30 most preferably at least 40 mg of any one flavonoid aglycone; and (g) at least 30 preferably at least 40 most preferably at least 50 mg of any one flavonoid glucoside; wherein the meal comprises 75 1000 mg of total flavonoid aglycone and flavonoid glucoside wherein the meal comprises no more than 250 mg of any one flavonoid aglycone wherein the meal comprises no more than 250 mg of any one flavonoid glucoside.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11191182 | 2011-11-29 | ||
| PCT/EP2012/073846 WO2013079536A1 (en) | 2011-11-29 | 2012-11-28 | A meal intended for human consumption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00932A true IN2014MN00932A (en) | 2015-04-17 |
Family
ID=47226200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN932MUN2014 IN2014MN00932A (en) | 2011-11-29 | 2012-11-28 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9386792B2 (en) |
| EP (1) | EP2785201A1 (en) |
| CN (1) | CN104039170A (en) |
| AU (1) | AU2012343964B2 (en) |
| BR (1) | BR112014010107A2 (en) |
| CA (1) | CA2852032A1 (en) |
| EA (1) | EA027364B1 (en) |
| IN (1) | IN2014MN00932A (en) |
| WO (1) | WO2013079536A1 (en) |
| ZA (1) | ZA201402770B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015182955A (en) * | 2014-03-20 | 2015-10-22 | 学校法人中部大学 | GLP-1 secretion promoter |
| CN111096972B (en) * | 2020-02-25 | 2023-07-14 | 成都医学院 | A pharmaceutical composition for preventing and/or treating Alzheimer's disease |
| WO2021252467A1 (en) * | 2020-06-09 | 2021-12-16 | H.J. Heinz Company Brands Llc | Modular meal system |
| USD1057556S1 (en) | 2021-10-29 | 2025-01-14 | H. J. Heinz Company Brands Llc | Tray |
| CN115645431B (en) * | 2022-12-12 | 2023-03-21 | 汤臣倍健股份有限公司 | Composition and application thereof |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996039053A2 (en) | 1995-06-06 | 1996-12-12 | Campbell Soup Company | Mineral supplements for dietetic food |
| US6039989A (en) | 1995-06-06 | 2000-03-21 | Campbell Soup Company | Prepackaged therapeutic meal for treatment of diet-responsive conditions |
| MXPA02000053A (en) * | 1999-07-05 | 2003-07-21 | Idea Ag | A method for the improvement of transport across adaptable semi-permeable barriers. |
| US20020054924A1 (en) * | 2000-04-13 | 2002-05-09 | Leahy Margaret M. | Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor |
| AU2001278161A1 (en) | 2000-08-08 | 2002-02-18 | Advanced Functional Foods International, Inc. | Nutritional supplement for the management of weight |
| US6808727B2 (en) | 2001-07-20 | 2004-10-26 | Emanuel S. Kemeny | Meal-equivalent food bar |
| US7030092B1 (en) * | 2001-08-24 | 2006-04-18 | Small Giant L.L.C. | Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins. |
| US6585998B2 (en) * | 2001-11-13 | 2003-07-01 | Rudolph Cartwright | Nutraceutical composition |
| US20040001817A1 (en) * | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
| US7767245B2 (en) | 2003-09-12 | 2010-08-03 | Ray And Terry's Health Products, Inc. | Meal replacement beverage |
| US8142809B2 (en) | 2004-08-25 | 2012-03-27 | Regent of the Univ. of Minnesota | Compositions and methods to lower glycohemoglobin levels |
| WO2006074278A2 (en) * | 2005-01-05 | 2006-07-13 | Mitsunori Ono | Compositions for treating diabetes or obesity |
| US7977319B1 (en) * | 2006-04-03 | 2011-07-12 | Scott David Levine | Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins |
| US20080305096A1 (en) | 2007-06-07 | 2008-12-11 | Unicity International, Inc. | Method and composition for providing controlled delivery of biologically active substances |
| US20100093678A1 (en) * | 2008-10-10 | 2010-04-15 | The University Of Georgia Research Foundation, Inc | Compositions and methods of the treatment of obesity and osteoporosis |
| WO2010105253A2 (en) * | 2009-03-13 | 2010-09-16 | The Salk Institute For Biological Studies | Methods and compositions for treating complications of diabetes and vascular diseases using flavones |
| EP2316271A1 (en) | 2009-10-26 | 2011-05-04 | ET & DS Company Ltd | Meal replacement in the form of a food product to be cooked, such as a bread, and an accompanying food product such as a sandwich spread. |
| WO2011060307A2 (en) | 2009-11-13 | 2011-05-19 | Jingxuan Kang | Food products having multiple health benefits |
| JP2013512662A (en) | 2009-12-07 | 2013-04-18 | レオナルド カレラ， | Low carbohydrate, high protein, fiber rich gelato formulation and method of manufacture |
| WO2011147862A1 (en) * | 2010-05-28 | 2011-12-01 | Unilever Plc | Compositions for dietary health management |
| KR20130140715A (en) * | 2010-10-14 | 2013-12-24 | 아샤 누트리션 사이언시스, 인코퍼레이티드 | Optimized nutritional formulations, methods for selection of tailored diets therefrom, and methods of use thereof |
| CN102077949B (en) | 2011-01-27 | 2013-01-16 | 北京康比特体育科技股份有限公司 | Diet meal replacement nutrition bar and preparation method thereof |
| CN102224933B (en) | 2011-05-13 | 2013-07-17 | 烟台新时代健康产业有限公司 | Composition and healthcare food assisting regulation of blood fat and applications thereof |
| US20130095204A1 (en) * | 2011-10-14 | 2013-04-18 | Zeina Jouni | Nutritional phytonutrient compositions |
| JP2015505320A (en) * | 2012-01-16 | 2015-02-19 | グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー２、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｎｏ．２ Ｌｉｍｉｔｅｄ | Compositions and methods for the treatment of diabetes and / or obesity |
| US9132117B2 (en) * | 2013-06-17 | 2015-09-15 | Kgk Synergize, Inc | Compositions and methods for glycemic control of subjects with impaired fasting glucose |
-
2012
- 2012-11-28 BR BR112014010107A patent/BR112014010107A2/en not_active Application Discontinuation
- 2012-11-28 IN IN932MUN2014 patent/IN2014MN00932A/en unknown
- 2012-11-28 EA EA201491050A patent/EA027364B1/en not_active IP Right Cessation
- 2012-11-28 WO PCT/EP2012/073846 patent/WO2013079536A1/en not_active Ceased
- 2012-11-28 AU AU2012343964A patent/AU2012343964B2/en not_active Ceased
- 2012-11-28 CN CN201280058728.9A patent/CN104039170A/en active Pending
- 2012-11-28 EP EP12791209.5A patent/EP2785201A1/en not_active Withdrawn
- 2012-11-28 CA CA2852032A patent/CA2852032A1/en not_active Abandoned
- 2012-11-28 US US14/359,487 patent/US9386792B2/en not_active Expired - Fee Related
-
2014
- 2014-04-15 ZA ZA2014/02770A patent/ZA201402770B/en unknown
-
2016
- 2016-06-10 US US15/179,203 patent/US9750272B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2785201A1 (en) | 2014-10-08 |
| US20160286841A1 (en) | 2016-10-06 |
| CN104039170A (en) | 2014-09-10 |
| US9750272B2 (en) | 2017-09-05 |
| US20140308392A1 (en) | 2014-10-16 |
| WO2013079536A1 (en) | 2013-06-06 |
| CA2852032A1 (en) | 2013-06-06 |
| ZA201402770B (en) | 2015-11-25 |
| EA027364B1 (en) | 2017-07-31 |
| BR112014010107A2 (en) | 2017-04-25 |
| US9386792B2 (en) | 2016-07-12 |
| AU2012343964B2 (en) | 2015-02-05 |
| EA201491050A1 (en) | 2014-09-30 |
| AU2012343964A1 (en) | 2014-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Harwood et al. | A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties | |
| Shen et al. | Green tea and bone metabolism | |
| BR112012015753A2 (en) | high protein and low calorie nutritional composition for stimulating muscle protein synthesis | |
| IN2014MN00932A (en) | ||
| WO2012088519A8 (en) | Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders | |
| NZ602249A (en) | Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders | |
| MX2010001805A (en) | Nutritious snack products. | |
| NO20085374L (en) | Use of phytate as a means of inhibiting dissolution of crystals of calcium salts to prevent osteoporosis | |
| WO2006108582A3 (en) | Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis | |
| MY150595A (en) | Nutritional composition to promote healthy development and growth | |
| MX2008014265A (en) | Structured lipid compositions and methods of formulation thereof. | |
| MX2009004814A (en) | Nutritional products comprising saccharide oligomers. | |
| BRPI0412210A (en) | reduced trans fat product | |
| BRPI0515411A (en) | mano-oligosaccharide composition, dietary composition, and method for reducing body fat or abdominal fat ratios in a human | |
| CR10698A (en) | FOOD COMPOSITION | |
| FI20065593A7 (en) | Method for preparing products containing galactooligosaccharides and their use | |
| WO2008058355A3 (en) | Descriptive report of patent of invention of the medicament 'atorvastatin + metformin' in combined form for cardiovascular diseases | |
| TW200612903A (en) | Use of trisubstituted benzopyranones | |
| Muthuvel et al. | Harnessing nutritional powerhouse: millets and probiotics in anticancer therapy | |
| Polamarasetti et al. | Nutrition planning during the COVID-19 pandemic for aging immunity | |
| BR112017011122A2 (en) | compositions, in vitro and in vivo methods for inhibiting an enzyme, non-therapeutic method for weight reduction, method for reducing caloric absorption, methods for treating or preventing obesity and hyperglycemia and / or hyperlipidemia in a subject and use of a composition? | |
| IN2012MN02476A (en) | ||
| JP2006020606A (en) | Composition for health food for obesity prevention and amelioration | |
| WO2007146559A3 (en) | Nutritional composition and method of making the same | |
| Willis et al. | An experimental study of a mediterranean-style diet supplemented with nuts and extra-virgin olive oil for cardiovascular disease risk reduction: the healthy hearts program (p12-021-19) |